Suspension of trading

Valuation Cutera

Stocks

Delayed OTC Markets Other stock markets 23:41:03 01/05/2025 +04			5-day change	1st Jan Change
0.008300 ^USD	-24.20%		-.--%	-

05-04	Cutera, Inc. Appoints Chris House as Chief Technology Officer	CI
12-18	Cutera®? Announces New FDA Clearances for Truflex®? to Support Rehabilitation, Recovery and Muscle Wellness	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2018	2019	2020	2021	2022	2023
Market Cap ¹	236.6	509.7	425.1	742	867.4	70.55
Change	-	115.39%	-16.59%	74.53%	16.9%	-91.87%
Enterprise Value (EV) ¹	202.1	484.8	404.1	729.2	982	358.9
Change	-	139.91%	-16.65%	80.47%	34.66%	-63.46%
P/E Ratio	-7.62x	-40.7x	-16.9x	376x	-10.1x	-0.43x
PBR	5.13x	11.2x	7.49x	13.1x	-57.3x	-0.41x
PEG	-	0.7x	-0.3x	-3x	0x	-0x
Capitalization / Revenue	1.45x	2.8x	2.88x	3.21x	3.44x	0.33x
EV / Revenue	1.24x	2.67x	2.74x	3.15x	3.89x	1.69x
EV / EBITDA	-16.6x	-48.9x	-19.6x	217x	-27.6x	-2.64x
EV / EBIT	-15.1x	-42.3x	-18.3x	362x	-25.7x	-2.49x
EV / FCF	41.7x	102x	-61.1x	66.8x	-21.3x	-3.16x
FCF Yield	2.4%	0.98%	-1.64%	1.5%	-4.7%	-31.7%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-2.234	-0.88	-1.431	0.11	-4.392	-8.19
Distribution rate	-	-	-	-	-	-
Net sales ¹	162.7	181.7	147.7	231.3	252.4	212.4
EBITDA ¹	-12.18	-9.916	-20.63	3.356	-35.57	-135.8
EBIT ¹	-13.39	-11.46	-22.02	2.012	-38.19	-143.9
Net income ¹	-30.77	-12.35	-23.88	2.062	-82.34	-162.8
Net Debt ¹	-34.56	-24.89	-21.04	-12.74	114.6	288.3
Reference price ²	17.020000	35.810000	24.110000	41.320000	44.220000	3.525000
Nbr of stocks (in thousands)	13,904	14,233	17,633	17,957	19,615	20,015
Announcement Date	18/03/19	16/03/20	23/03/21	01/03/22	07/04/23	10/05/24